A detailed history of Planning Capital Management Corp transactions in Pharma Cyte Biotech, Inc. stock. As of the latest transaction made, Planning Capital Management Corp holds 100 shares of PMCB stock, worth $216. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$216
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$1.95 - $2.52 $195 - $252
100 New
100 $196,000

Others Institutions Holding PMCB

About PharmaCyte Biotech, Inc.


  • Ticker PMCB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,750,100
  • Market Cap $44.8M
  • Description
  • PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types o...
More about PMCB
Track This Portfolio

Track Planning Capital Management Corp Portfolio

Follow Planning Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Planning Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Planning Capital Management Corp with notifications on news.